PFIZER LLEGA A UN ACUERDO CON 10.000 DEMANDANTES Y PAGA 100M $ POR SU MEDICAMENTO PARA LA ACIDEZ ZANTAC, QUE PRODUCE CÁNCER. ES DECIR, DISMINUYE LA ACIDEZ DE ESTÓMAGO, Y COMO EFECTO SEGUNDARIO PRODUCE CÁNCER.
SI ESTO PASA CON UN MEDICAMENTO QUE HA TENIDO SU DESARROLLO NORMAL, PASANDO TODAS LAS FASES Y HACIÉNDOSE LAS PRUEBAS OPORTUNAS ANTES DE COMERCIALIZARLO, IMAGINAD QUÉ CREDIBILIDAD TIENE QUIEN DIGA QUE UNA "VACUNA" DESARROLLADA EN 6 MESES ES "SEGURA".
LAS FARMACÉUTICAS SON UNA MAFIA QUE JAMÁS QUIERE CURAR. QUIEREN ENFERMOS MEDICADOS DE POR VIDA.
PFIZER LLEGA A UN ACUERDO CON 10.000 DEMANDANTES Y PAGA 100M $ POR SU MEDICAMENTO PARA LA ACIDEZ ZANTAC, QUE PRODUCE CÁNCER. ES DECIR, DISMINUYE LA ACIDEZ DE ESTÓMAGO, Y COMO EFECTO SEGUNDARIO PRODUCE CÁNCER.
SI ESTO PASA CON UN MEDICAMENTO QUE HA TENIDO SU DESARROLLO NORMAL, PASANDO TODAS LAS FASES Y HACIÉNDOSE LAS PRUEBAS OPORTUNAS ANTES DE COMERCIALIZARLO, IMAGINAD QUÉ CREDIBILIDAD TIENE QUIEN DIGA QUE UNA "VACUNA" DESARROLLADA EN 6 MESES ES "SEGURA".
LAS FARMACÉUTICAS SON UNA MAFIA QUE JAMÁS QUIERE CURAR. QUIEREN ENFERMOS MEDICADOS DE POR VIDA.
At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?
Pinterest (PINS) Stock Sinks As Market Gains
Pinterest (PINS) closed at $71.75 in the latest trading session, marking a -0.18% move from the prior day. This change lagged the S&P 500's daily gain of 0.1%. Meanwhile, the Dow gained 0.9%, and the Nasdaq, a tech-heavy index, lost 0.59%.
Heading into today, shares of the digital pinboard and shopping tool company had lost 17.41% over the past month, lagging the Computer and Technology sector's loss of 5.38% and the S&P 500's gain of 0.71% in that time.
Investors will be hoping for strength from PINS as it approaches its next earnings release. The company is expected to report EPS of $0.07, up 170% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $467.87 million, up 72.05% from the year-ago period.
